General Cardiology

Get Moving: ACC Provides Direction on Activity for CVD Patients

The American College of Cardiology (ACC) has issued new directions for prescribing…

Dapagliflozin in the Treatment of COVID-19: Insights from the DARE-19 Trial

SGLT-2 inhibitors have demonstrated efficacy in various cardiometabolic conditions, including heart failure,…